Novel intraocular shielding device for eye plaque brachytherapy using magnetite nanoparticles: A proof-of-concept study using radiochromic film and Monte Carlo simulations
Eye plaque brachytherapy is a mainstay treatment for uveal melanomas despite potential toxicities to normal tissues. This work proposes a nanoparticle ferrofluid as a novel intraocular shielding device. With a modified magnetic plaque, the shielding particles are drawn to the tumor surface, attenuating dose beyond the tumor while maintaining prescription dose to the target.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Courtney C. Oare, James P. Dailey, Bruce Gerbi, Clara Ferreira Source Type: research
More News: Brachytherapy | Cancer & Oncology | Eye Cancers | Nanotechnology | Study | Toxicology | Uveal Melanoma